DK1003494T3 - (d)-metadon, et ikke-opioidt analgetikum - Google Patents

(d)-metadon, et ikke-opioidt analgetikum

Info

Publication number: DK1003494T3
Authority: DK; Denmark
Prior art keywords: alpha; subject; methadone; normethadol; acetylmethadol
Prior art date: 1997-01-22

Application number

DK98904609T

Other languages

English (en)

Inventor

Charles E Inturrisi

Original Assignee

Cornell Res Foundation Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-22

Filing date

1998-01-21

Publication date

2007-07-16

1998-01-21 Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc

2007-07-16 Application granted granted Critical

2007-07-16 Publication of DK1003494T3 publication Critical patent/DK1003494T3/da

Links

229960001797 methadone Drugs 0.000 title 1
229940121367 non-opioid analgesics Drugs 0.000 title 1
102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 2
108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 2
KYHAUJGXNUJCTC-LPHOPBHVSA-N (3s,6s)-6-(methylamino)-4,4-diphenylheptan-3-ol Chemical compound C=1C=CC=CC=1C(C[C@H](C)NC)([C@@H](O)CC)C1=CC=CC=C1 KYHAUJGXNUJCTC-LPHOPBHVSA-N 0.000 abstract 1
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
229950005506 acetylmethadol Drugs 0.000 abstract 1
-1 d-alpha-normethadol Chemical compound 0.000 abstract 1
USSIQXCVUWKGNF-KRWDZBQOSA-N dextromethadone Chemical compound C=1C=CC=CC=1C(C[C@H](C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-KRWDZBQOSA-N 0.000 abstract 1
229950004655 dimepheptanol Drugs 0.000 abstract 1
XBMIVRRWGCYBTQ-AVRDEDQJSA-N levacetylmethadol Chemical compound C=1C=CC=CC=1C(C[C@H](C)N(C)C)([C@@H](OC(C)=O)CC)C1=CC=CC=C1 XBMIVRRWGCYBTQ-AVRDEDQJSA-N 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK98904609T 1997-01-22 1998-01-21 (d)-metadon, et ikke-opioidt analgetikum DK1003494T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3530897P	1997-01-22	1997-01-22
PCT/US1998/001088 WO1998031358A1 (en)	1997-01-22	1998-01-21	d-METHADONE, A NONOPIOID ANALGESIC

Publications (1)

Publication Number	Publication Date
DK1003494T3 true DK1003494T3 (da)	2007-07-16

Family

ID=21881853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98904609T DK1003494T3 (da)	1997-01-22	1998-01-21	(d)-metadon, et ikke-opioidt analgetikum

Country Status (12)

Country	Link
US (1)	US6008258A (da)
EP (1)	EP1003494B1 (da)
JP (2)	JP4514241B2 (da)
AT (1)	ATE357226T1 (da)
AU (1)	AU6244898A (da)
CA (1)	CA2278422C (da)
DE (1)	DE69837387T2 (da)
DK (1)	DK1003494T3 (da)
ES (1)	ES2283049T3 (da)
MA (1)	MA24794A1 (da)
PT (1)	PT1003494E (da)
WO (1)	WO1998031358A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1061924A1 (en) *	1998-03-09	2000-12-27	Trustees Of Tufts College	Treatment of compulsive behaviours in man and animals
US20060167114A1 (en) *	1998-03-09	2006-07-27	Louis Shuster	Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20070197651A1 (en) *	1998-03-09	2007-08-23	Tufts University	Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
EP1102589B1 (en) *	1998-07-16	2006-11-02	Memorial Sloan-Kettering Institute For Cancer Research	Topical compositions comprising an opioid analgesic and an nmda antagonist
US6897242B1 (en) *	1999-02-24	2005-05-24	Judson J. Somerville	Non-racemic mixtures of d- and l- methadone and method of treating pain
WO2001076522A1 (en) *	2000-04-07	2001-10-18	Ultramed International, Inc.	Maintaining abstinence after detoxification from opiate addiction
KR20030060771A (ko)	2000-04-28	2003-07-16	메모리얼 슬로안-케터링 캔서 센터	국소용 마취제/아편양약물 제제 및 이들의 용도
US7820688B2 (en)	2001-04-27	2010-10-26	Memorial Sloan-Kettering Cancer Center	Topical anesthetic/opioid formulations and uses thereof
CA2473536A1 (en) *	2002-01-16	2003-07-31	Endo Pharmaceuticals, Inc.	Pharmaceutical composition and method for treating disorders of the central nervous system
WO2003061594A2 (en) *	2002-01-23	2003-07-31	The Regents Of The University Of California	Methods and compositions for reducing the development of drug tolerance and/or physical dependence
WO2004041154A2 (en) *	2002-05-13	2004-05-21	Endo Pharmaceuticals Inc.	Abuse-resistant opioid dosage form
JP2006500395A (ja) *	2002-09-09	2006-01-05	エンドファーマシューティカルズインコーポレーテッド	組み合わされた即時放出及び徐放の鎮痛組成物
US20040180915A1 (en) *	2003-03-14	2004-09-16	Xanodyne Pharmacal, Inc.	Methadone-containing compositions for parenteral administration and method of use thereof
US20040202717A1 (en)	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
US20100010096A1 (en) *	2006-10-27	2010-01-14	John Charin Somberg	Methadone chiral isolate as an improved pharmaceutical
US20100048605A1 (en) *	2006-12-11	2010-02-25	University Of Kentucky Research Foundation	Synergistic effects of combinations of nornicotine and opioids for the treatment of pain
US9468611B2 (en)	2012-09-27	2016-10-18	Relmada Therapeutics, Inc.	d-Methadone for the treatment of psychiatric symptoms
MX2019009038A (es) *	2017-01-31	2019-12-09	L Manfredi Paolo	D-metadona y sus derivados para uso en el tratamiento de trastornos del sistema nervioso.
WO2018183320A1 (en) *	2017-03-31	2018-10-04	Depco, Inc.	Therapeutic putty having analgesics and/or counterirritants
US12637411B2 (en)	2019-01-30	2026-05-26	Mggm Llc	Structurally modified opioids for prevention and treatment of diseases and conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3895056A (en) *	1972-12-26	1975-07-15	Lilly Co Eli	Alpha-d1-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
US5321012A (en) *	1993-01-28	1994-06-14	Virginia Commonwealth University Medical College	Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5352683A (en) *	1993-03-05	1994-10-04	Virginia Commonwealth University Medical College Of Virginia	Method for the treatment of chronic pain
CA2115792C (en) *	1993-03-05	2005-11-01	David J. Mayer	Method for the treatment of pain

1998
- 1998-01-21 WO PCT/US1998/001088 patent/WO1998031358A1/en not_active Ceased
- 1998-01-21 ES ES98904609T patent/ES2283049T3/es not_active Expired - Lifetime
- 1998-01-21 EP EP98904609A patent/EP1003494B1/en not_active Expired - Lifetime
- 1998-01-21 AT AT98904609T patent/ATE357226T1/de not_active IP Right Cessation
- 1998-01-21 DE DE69837387T patent/DE69837387T2/de not_active Expired - Lifetime
- 1998-01-21 DK DK98904609T patent/DK1003494T3/da active
- 1998-01-21 CA CA002278422A patent/CA2278422C/en not_active Expired - Lifetime
- 1998-01-21 US US09/010,239 patent/US6008258A/en not_active Expired - Lifetime
- 1998-01-21 JP JP53465698A patent/JP4514241B2/ja not_active Expired - Lifetime
- 1998-01-21 AU AU62448/98A patent/AU6244898A/en not_active Abandoned
- 1998-01-21 PT PT98904609T patent/PT1003494E/pt unknown
- 1998-01-22 MA MA24934A patent/MA24794A1/fr unknown
2009
- 2009-09-14 JP JP2009211687A patent/JP2010013477A/ja active Pending

Also Published As

Publication number	Publication date
PT1003494E (pt)	2007-06-06
EP1003494B1 (en)	2007-03-21
AU6244898A (en)	1998-08-07
EP1003494A4 (en)	2002-10-16
EP1003494A1 (en)	2000-05-31
JP2001508797A (ja)	2001-07-03
MA24794A1 (fr)	1999-12-31
DE69837387D1 (de)	2007-05-03
ATE357226T1 (de)	2007-04-15
WO1998031358A1 (en)	1998-07-23
JP4514241B2 (ja)	2010-07-28
JP2010013477A (ja)	2010-01-21
ES2283049T3 (es)	2007-10-16
CA2278422C (en)	2007-11-13
DE69837387T2 (de)	2007-12-13
CA2278422A1 (en)	1998-07-23
US6008258A (en)	1999-12-28

Similar Documents

Publication	Publication Date	Title
MA24794A1 (fr)	1999-12-31	D-methadone, un analgesique nonopioique
IL128003A (en)	2003-06-24	MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR
DK0942740T3 (da)	2003-12-15	Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme
DE69733081D1 (de)	2005-05-25	Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
ATE301994T1 (de)	2005-09-15	Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
BR9910180A (pt)	2001-01-09	Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
FI965203A7 (fi)	1996-12-23	Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
FR12C0001I2 (fr)	2014-05-16	Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
NZ331189A (en)	1999-06-29	Method of detection of influenza virus using neuraminidase binders
ATE247461T1 (de)	2003-09-15	Formulierung zur intranasalen verabreichung
CA2146973A1 (en)	1994-05-11	Uses of tgf-.beta. receptor fragment as a therapeutic agent
FI823112A7 (fi)	1983-03-09	Nalbufiini-narkoottinen analgeettikoostumus ja menetelmä kivuntunnon poistamiseksi.
DK1063995T3 (da)	2003-03-10	Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
UA26403A (uk)	1999-08-30	Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
MY118828A (en)	2005-01-31	Substituted amino compounds and their use as substances having an analgesic effect
BR0110208A (pt)	2003-01-28	Composições e terapias para distúrbios associados com hiperlipidemia
ATE221391T1 (de)	2002-08-15	Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
TR200103680T2 (tr)	2002-07-22	IL-8 reseptör antagonistleri.
DK0846173T3 (da)	2006-01-16	Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
BG103872A (en)	2000-07-31	Glycoconjugates of 20(s)-camptotecin
EA199800866A1 (ru)	1999-06-24	Способ снятия боли
MY133169A (en)	2007-10-31	Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
SE9501881D0 (sv)	1995-05-19	New pharmacological use of AII-receptor antagonists
WO1998020835A3 (en)	1998-07-16	Method of treating hyperlipidemia in humans
CA2299400A1 (en)	1999-05-06	Method for treating disease-related or drug-induced dyskinesias